Universal Health International Group Holding Ltd
02211
Company Profile
Business description
Universal Health International Group Holding Ltd distributes and retails pharmaceutical products in Northeast China. The company operates its business through two segments: pharmaceutical retail and Distribution, (including import and export trade) include prescribed drugs, non-prescribed drugs (Chinese patent medicines, chemical preparations, antibiotics and biochemical drugs), traditional Chinese medicine decoction pieces, biological products, protein assimilation preparations, peptide hormones, blood products, disinfection products, medical equipment, etc. and majority of revnue comes from Distribution segment.
Contact
No. 14-1, Bei Yi Zhong Road
Tiexi District
Liaoning Province
Shenyang
CHNSector
Healthcare
Stock type
Defensive
Industry
Pharmaceutical Retailers
Fiscal Year End
30 June 2026
Employees
842
Stocks News & Analysis
stocks
Meta earnings: Strong end to 2025 as AI monetization begins to show
Investors please with latest results.
stocks
Why doesn’t the market like the earnings from this US tech giant?
Good quarter with AI demand ramping.
stocks
Our Tesla fair value increases meaningfully
Progress on Robotaxi and Optimus shows real world AI growth.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,164.80 | 94.40 | -1.02% |
| CAC 40 | 8,105.76 | 34.40 | 0.43% |
| DAX 40 | 24,515.60 | 206.14 | 0.85% |
| Dow JONES (US) | 49,071.56 | 55.96 | 0.11% |
| FTSE 100 | 10,197.74 | 25.98 | 0.26% |
| HKSE | 27,387.11 | 580.98 | -2.08% |
| NASDAQ | 23,685.12 | 172.33 | -0.72% |
| Nikkei 225 | 53,322.85 | 52.75 | -0.10% |
| NZX 50 Index | 13,423.18 | 74.57 | 0.56% |
| S&P 500 | 6,969.01 | 9.02 | -0.13% |
| S&P/ASX 200 | 8,869.10 | 86.00 | -0.96% |
| SSE Composite Index | 4,117.95 | 40.04 | -0.96% |